International Journal of Laboratory Hematology

Article	Citations
Absolute lymphocyte count is a prognostic marker in Covid‐19: A retrospective cohort review	71
Laboratory testing for suspected COVID‐19 vaccine–induced (immune) thrombotic thrombocytopenia	66
Evaluation of COVID‐19 coagulopathy; laboratory characterization using thrombin generation and nonconventional haemostasis assays	56
COVID‐19 and hematology findings based on the current evidences: A puzzle with many missing pieces	52
Ferritin levels in patients with COVID‐19: A poor predictor of mortality and hemophagocytic lymphohistiocytosis	51
Standardization of Prothrombin Time/International Normalized Ratio (PT/INR)	48
The relationship between serum erythropoietin, hepcidin, and haptoglobin levels with disease severity and other biochemical values in patients with COVID‐19	44
A meta‐analysis of SARS‐CoV‐2 patients identifies the combinatorial significance of D‐dimer, C‐reactive protein, lymphocyte, and neutrophil values as a predictor of disease severity	42
ADAMTS13 activity to von Willebrand factor antigen ratio predicts acute kidney injury in patients with COVID‐19: Evidence of SARS‐CoV‐2 induced secondary thrombotic microangiopathy	41
COVID‐19: Thrombosis, thromboinflammation, and anticoagulation considerations	36
Machine learning in health care and laboratory medicine: General overview of supervised learning and Auto‐ML	33
COVID‐19–related laboratory coagulation findings	29
SARS‐CoV‐2 infection induces soluble platelet activation markers and PAI‐1 in the early moderate stage of COVID‐19	28
Age‐ and sex‐specific pediatric reference intervals for neutrophil‐to‐lymphocyte ratio, lymphocyte‐to‐monocyte ratio, and platelet‐to‐lymphocyte ratio	26
International Council for Standardization in Haematology (ICSH) recommendations for laboratory measurement of ADAMTS13	25
International Council for Standardization in Haematology (ICSH) recommendations for processing of blood samples for coagulation testing	25
Increased von Willebrand factor antigen and low ADAMTS13 activity are related to poor prognosis in covid‐19 patients	24
Heparin dosage, level, and resistance in SARS‐CoV2 infected patients in intensive care unit	24
Clinical and hematological characteristics of 88 patients with COVID‐19	24
Comprehensive review of the impact of direct oral anticoagulants on thrombophilia diagnostic tests: Practical recommendations for the laboratory	24
Evaluation of eosinopenia as a diagnostic and prognostic indicator in COVID‐19 infection	23
A case of severe autoimmune hemolytic anemia after a receipt of a first dose of SARS‐CoV‐2 vaccine	22
Relationship of D‐dimer with severity and mortality in SARS‐CoV‐2 patients : A meta‐analysis	22
Validation of monocyte distribution width decisional cutoff for sepsis detection in the acute setting	21
Peripheral blood morphologic findings in patients with COVID‐19	21

Monocyte volumetric parameters and lymph index are increased in SARS‐CoV‐2 infection	21
Lymphopenia in critically ill COVID‐19 patients: A predictor factor of severity and mortality	21
International Council for Standardisation in Haematology (ICSH) recommendations for collection of blood samples for coagulation testing	21
Plasmablastic lymphoma: An update	21
Platelets: "multiple choice" effectors in the immune response and their implication in COVID‐19 thromboinflammatory process	20
Evaluation of Scopio Labs X100 Full Field PBS: The first high‐resolution full field viewing of peripheral blood specimens combined with artificial intelligence‐based morphological analysis	20
2021 update of the 2012 ICSH Recommendations for identification, diagnostic value, and quantitation of schistocytes: Impact and revisions	20
Neutrophil‐to‐lymphocyte ratio, a critical predictor for assessment of disease severity in patients with COVID‐19	20
Higher coagulation activity in hip fracture patients: A case‐control study using rotational thromboelastometry	20
The hemoglobinopathies, molecular disease mechanisms and diagnostics	19
The complicated relationships of heparin‐induced thrombocytopenia and platelet factor 4 antibodies with COVID‐19	19
Clinical assessment of the utility of metagenomic next‐generation sequencing in pediatric patients of hematology department	19
Kinetics of immune reconstitution after anti‐CD19 chimeric antigen receptor T cell therapy in relapsed or refractory acute lymphoblastic leukemia patients	18
COVID‐19 in patients with hematological malignancies: A retrospective case series	18
Diagnosis and treatment of thrombotic microangiopathy	18
Pooled analysis of monocyte distribution width in subjects with SARS‐CoV‐2 infection	16
Gene therapy for hemophilia: Current status and laboratory consequences	16
Interest of the cellular population data analysis as an aid in the early diagnosis of SARS‐CoV‐2 infection	15
Thrombosis and antiphospholipid antibodies in patients with SARS‐COV‐2 infection (COVID‐19)	14
Complex biological patterns of hematology parameters in childhood necessitating age‐ and sex‐specific reference intervals for evidence‐based clinical interpretation	14
Serum calprotectin (S100A8/A9) levels as a new potential biomarker of treatment response in Hodgkin lymphoma	14
How I investigate acquired megaloblastic anemia	14
Diagnostic and prognostic utility of WBC counts and cell population data in patients with COVID‐19	13
Unsupervised flow cytometry analysis in hematological malignancies: A new paradigm	13
Measuring residual anti‐Xa activity of direct factor Xa inhibitors after reversal with andexanet alfa	13
Circ_0009910 sponges miR‐491‐5p to promote acute myeloid leukemia progression through modulating B4GALT5 expression and PI3K/AKT signaling pathway	13
Adhesion molecule immunophenotype of bone marrow multiple myeloma plasma cells impacts the presence of malignant circulating plasma cells in peripheral blood	13
Peripheral lymphocyte subset alterations in COVID‐19 patients	12
COVID‐19 and the ABO blood group in pregnancy: A tale of two multiethnic cities	12
Lupus anticoagulant in patients with COVID‐19	12
International Council for Standardization in Haematology (ICSH) laboratory guidance for the verification of haemostasis analyser‐reagent test systems. Part 2: Specialist tests and calibrated assays	12
The hematology laboratory’s response to the COVID‐19 pandemic: A scoping review	12
Interpreting sulfhemoglobin and methemoglobin in patients with cyanosis: An overview of patients with M‐hemoglobin variants	12
Significance of RDW in predicting mortality in COVID‐19—An analysis of 622 cases	11
Monocyte distribution width adds prognostic value in detection of COVID‐19 respiratory failure	11
Multicentric evaluation of the new HemosIL Acustar® chemiluminescence ADAMTS13 activity assay	11
Performance evaluation of the new hematology analyzer UniCel DxH 900	11
Validation of the chromogenic Bethesda assay for factor VIII inhibitors in hemophilia a patients receiving Emicizumab	11
Using a low–molecular weight heparin–calibrated anti–factor Xa assay to assess the concentration of apixaban and rivaroxaban	11
Acute myeloid leukemia with mutated NPM1 mimics acute promyelocytic leukemia presentation	11
Analysis of hematological indexes of COVID‐19 patients from fever clinics in Suzhou, China	11
Changes in peripheral blood cellular morphology as diagnostic markers for COVID‐19 infection	11
Recurrent PROC and novel PROS1 mutations in Vietnamese patients diagnosed with idiopathic deep venous thrombosis	11
Are the DOAC plasma level thresholds appropriate for clinical decision‐making? A reappraisal using thrombin generation testing	11
Comparison of RNA‐ and DNA‐based methods for measurable residual disease analysis in NPM1‐mutated acute myeloid leukemia	11
Plasma levels do not predict thrombin generation in patients taking direct oral anticoagulants	10
Trimester‐specific thromboelastic values and coagulation activation markers in pregnancy compared across trimesters and compared to the nonpregnant state	10
To B‐ or not to B‐: A review of lineage switched acute leukemia	10
Update on platelet procoagulant mechanisms in health and in bleeding disorders	10
A multi‐laboratory assessment of lupus anticoagulant assays performed on the ACL TOP 50 family for harmonized testing in a large laboratory network	10

Is neutrophilia associated with mortality in COVID‐19 patients? A meta‐analysis and meta‐regression	10
Upregulation of ATIC in multiple myeloma tissues based on tissue microarray and gene microarrays	10
Platelet factor 4 triggers thrombo‐inflammation by bridging innate and adaptive immunity	10
Effects of circadian variation, lifestyle and environment on hematological parameters: A narrative review	10
Hemophagocytic histiocytosis in severe SARS‐CoV‐2 infection: A bone marrow study	10
Evaluation of measurable residual disease in multiple myeloma by multiparametric flow cytometry: Current paradigm, guidelines, and future applications	9
Increased monocyte distribution width in COVID‐19 and sepsis arises from a complex interplay of altered monocyte cellular size and subset frequency	9
Diagnostic value of white blood cell parameters for COVID‐19: Is there a role for HFLC and IG?	9
Increasing ferritin predicts early death in adult hemophagocytic lymphohistiocytosis	9
Plasma hemoglobin: A method comparison of six assays for hemoglobin and hemolysis index measurement	9
Laboratory approach to investigation of anemia in pregnancy	9
Neutrophil‐to‐lymphocyte and platelet‐to‐lymphocyte ratios as prognostic biomarkers in polycythemia vera	9
International Council for Standardization in Haematology (ICSH) laboratory guidance for the evaluation of haemostasis analyser‐reagent test systems. Part 1: Instrument‐specific issues and commonly use	9
TACC3 expression as a prognostic factor in aggressive types of adult T‐cell leukemia/lymphoma patients	9
Application of an optimized interpretation model in capillary hemoglobin electrophoresis for newborn thalassemia screening	9
ADAMTS13 testing update: Focus on laboratory aspects of difficult thrombotic thrombocytopenic purpura diagnoses and effects of new therapies	9
Overall hemostasis potential and aPTT‐clot waveform analysis as powerful laboratory diagnostic tools for identification of hemophilia A patients with unexpected bleeding phenotype	9
The effect of haemoglobin, albumin, lymphocyte and platelet score on the prognosis in patients with multiple myeloma	9
How to best monitor bivalirudin anticoagulant effect for ECMO and VAD—Comparison of four assay methods	9
Features of serum complement C3 and C4 levels in autoimmune hemolytic anemia patients	8
Evaluation of the accuracy of immature granulocyte percentage in predicting pediatric serious bacterial infection	8
The effect of DOAC‐Stop® on several oral and parenteral anticoagulants	8
COVID‐19 patient with immune thrombocytopenic purpura	8
Harmonizing platelet function analyzer testing and reporting in a large laboratory network	8
Reduced activity of B lymphocytes, recognised by Sysmex XN‐2000™ haematology analyser, predicts mortality in patients with coronavirus disease 2019	8
Diagnosing heparin‐induced thrombocytopenia: The need for accuracy and speed	8
Circulating tumor DNA by high‐throughput sequencing of T cell receptor monitored treatment response and predicted treatment failure in T cell lymphomas	8
Cell population data: Could a routine hematology analyzer aid in the differential diagnosis of COVID‐19?	8
Laboratory methods for monitoring argatroban in heparin‐induced thrombocytopenia	8
Identification of thalassemia gene cluster deletion by long‐read whole‐genome sequencing (LR‐WGS)	8
New insights into genetic characteristics between multiple myeloma and COVID‐19: An integrative bioinformatics analysis of gene expression omnibus microarray and the cancer genome atlas data	8
Major rise of a chronic lymphoid leukemia clone during the course of COVID‐19	8
Detection and significance of green inclusions in peripheral blood neutrophils and monocytes	8
The characteristic peripheral blood morphological features of hospitalized patients infected with COVID‐19	8
Pneumatic tube transport of blood samples affects global hemostasis and platelet function assays	8
Estimating plasma volume using the Strauss‐derived formula may improve prognostication in polycythemia vera	8
Resolution of epoetin‐induced pure red cell aplasia, successful re‐challenge with roxadustat	8
Low clinical utility of testing for anti‐platelet factor 4 in asymptomatic individuals after ChAdOx1 nCoV‐19 vaccine	8
Expression and prognostic relevance of long noncoding RNAs CRNDE and AOX2P in adult acute myeloid leukemia	8
Study of in vitro thrombin generation after neutralization of heparin	8
Transient increase in blast count following COVID‐19 infection mimicking acute leukemia	7
CaMKIIγ regulates the viability and self‐renewal of acute myeloid leukaemia stem‐like cells by the Alox5/NF‐κB pathway	7
The integration of Sysmex XN‐9100’ WPC channel reflex testing in the detection of reactive versus malignant blood samples	7
Downregulation of Lymphoid enhancer‐binding factor 1 (LEF‐1) expression (by immunohistochemistry and/ flow cytometry) in chronic Lymphocytic Leukemia with atypical immunophenotypic and cytologi	7
Laboratory practices for manual blood film review: Results of an IQMH patterns of practice survey	7
Association of FOXP3 gene polymorphisms with chronic immune thrombocytopenia in a Chinese Han population	7
The lncRNA SLCO4A1‐AS1/miR‐876‐3p/RBBP6 axis regulates cell proliferation and apoptosis in acute lymphocytic leukemia via the JNK signaling pathway	7
Cell Population Data NE‐WX, NE‐FSC, LY‐Y of Sysmex XN‐9000 can provide additional information to differentiate macrocytic anaemia from myelodysplastic syndrome: A preliminary study	7
Study of thrombin generation with St Genesia to evaluate xaban pharmacodynamics: Analytical performances over 18 months	7
Standardization and harmonization in hematology: Instrument alignment, quality control materials, and commutability issue	7
Development and exacerbation of autoimmune hemolytic anemia following COVID‐19 vaccination: A systematic review	7
Erythropoiesis changes with increasing age in the elderly Chinese	7
Mutations in myelodysplastic syndromes: Core abnormalities and CHIPping away at the edges	7
Immune thrombocytopenic purpura after COVID‐19 infection	7
Review of coagulation preanalytical variables with update on the effect of direct oral anticoagulants	7
How I investigate minimal residual disease in acute lymphoblastic leukemia	7
Distinguishing iron deficiency from beta‐thalassemia trait by new generation ektacytometry	7
Predicting bacteraemia in maternity patients using full blood count parameters: A supervised machine learning algorithm approach	7
Mutation profile and prognostic relevance in elderly patients with de novo acute myeloid leukemia treated with decitabine‐based chemotherapy	7
Usefulness of automated fragmented red blood cell percentage in the diagnosis of paediatric haemolytic uraemic syndrome	7
The HScore for secondary hemophagocytic lymphohistiocytosis, calculated without a marrow biopsy, is consistently low in patients with COVID‐19	7
Thrombin generation abnormalities in Quebec platelet disorder	7
Continuous reference curves for common hematology markers in the CALIPER cohort of healthy children and adolescents on the Sysmex XN‐3000 system	7
Screening method for congenital dysfibrinogenemia using clot waveform analysis with the Clauss method	7
Comparison of flow cytometry and next‐generation sequencing in minimal residual disease monitoring of acute myeloid leukemia: One institute’s practical clinical experience	7
CXCL2 benefits acute myeloid leukemia cells in hypoxia	7
Stability and comparison of complete blood count parameters between capillary and venous blood samples	7
Peripheral granular lymphocytopenia and dysmorphic leukocytosis as simple prognostic markers in COVID‐19	7
Comparative sequencing data analysis of Ion Torrent and MinION sequencing platforms using a clinical diagnostic haematology panel	6
Thrombin generation abnormalities in commonly encountered platelet function disorders	6
Rapid screening of dengue fever using research parameters from new generation hematological analyzers	6
A study to compare Hematopoietic Progenitor Cell count determined on a next‐generation automated cell counter with flow cytometric CD34 count in peripheral blood and the harvested peripheral blood ste	6
Laboratory evaluation and prognostication among adults and children with CEBPA‐mutant acute myeloid leukemia	6
Gastrointestinal bleeding in a newborn infant with congenital factor X deficiency and COVID‐19—A common clinical feature between a rare disorder and a new, common infection	6
Use of Sysmex XN‐10 red blood cell parameters for screening of hereditary red blood cell diseases and iron deficiency anaemia	6
How I investigate dysgranulopoiesis	6
Reduced expansion of CD94/NKG2C+ NK cells in chronic lymphocytic leukemia and CLL‐like monoclonal B‐cell lymphocytosis is not related to increased human cytomegalovirus seronegativity or	6
Pitfalls in CALR exon 9 mutation detection: A single‐center experience in 571 positive patients	6
Differences between capillary and venous blood counts in children—A data mining approach	6
High‐level MYC expression associates with poor survival in patients with acute myeloid leukemia and collaborates with overexpressed p53 in leukemic transformation in patients with myelodysplastic synd	6

Spectrum mutations of PRF1, UNC13D, STX11, and STXBP2 genes in Vietnamese patients with hemophagocytic lymphohistiocytosis	6
Aiding clinical assessment of neonatal sepsis using hematological analyzer data with machine learning techniques	6
Neutrophil‐to‐lymphocyte ratio is independently associated with COVID‐19 severity: An updated meta‐analysis based on adjusted effect estimates	6
Variability among commercial batches of normal pooled plasma in lupus anticoagulant testing	6
High immature platelet fraction with reduced platelet count on hospital admission. Can it be useful for COVID‐19 diagnosis?	6
Molecular and clinical profile of congenital fibrinogen disorders in Iran, identification of two novel mutations	6
Red cell distribution width and in‐hospital mortality in septic shock: A public database research	6
Reference intervals of white blood cell parameters for healthy adults in japan	6
Do congenital bleeding disorders have a protective effect against COVID‐19? A prospective study	6
Full spectrum flow cytometry in the clinical laboratory	6
Enumeration and phenotyping of circulating microvesicles by flow cytometry and nanoparticle tracking analysis: Plasma versus serum	6
Leukemic stem cells shall be searched in the bone marrow before “tyrosine kinase inhibitor‐discontinuation” in chronic myeloid leukemia	6
Parameters of the complete blood count predict in hospital mortality	6
Screening of myelodysplastic syndrome using cell population data obtained from an automatic hematology analyzer	6
Impact of variation in reagent combinations for one‐stage clotting assay on assay discrepancy in nonsevere haemophilia A	6
Rebuttal of a paper submitted by Hans‐Inge Bengtsson	6
C‐reactive protein‐induced activated partial thromboplastin time prolongation in heparinized samples is attenuated by elevated factor VIII	5
Evaluation and comparison of the new Mindray BC‐6200 hematology analyzer with ADVIA 2120i	5
Circulating Hodgkin cells: A clinicopathologic analysis of seven patients and a review of the literature	5
Core‐binding factor acute myeloid leukemia with inv(16): Older age and high white blood cell count are risk factors for treatment failure	5
Biological variation data and analytical specification goal estimates of the thrombin generation assay with and without thrombomodulin in healthy individuals	5
Quantification and optimization of clot retraction in washed human platelets by Sonoclot coagulation analysis	5
Functional multigenic variations associated with hodgkin lymphoma	5
Additional mutations in IDH1/2‐mutated patients with acute myeloid leukemia	5
Establishing Ghanaian adult reference intervals for hematological parameters controlling for latent anemia and inflammation	5
Viscoelastic testing: Critical appraisal of new methodologies and current literature	5
Experimental evaluation of deep learning method in reticulocyte enumeration in peripheral blood	5
Complete blood count and cell population data parameters from the Abbott Alinity hq analyzer are useful in differentiating myelodysplastic syndromes from other forms of cytopenia	5
Automated differential diagnosis method for iron deficiency anemia and beta thalassemia trait based on iterative Chi2 feature selector	5
Early detection of Candida parapsilosis sepsis in peripheral blood as a result of cytografic changes on the Sysmex XN‐3000 hematology analyzer	5
IgE monoclonal gammopathy: The clinical relevance to perform the immunofixation using IgE antisera	5
A stepwise haematological screening and whole‐exome sequencing reveal multiple mutations from SUPT5H causing an elevation of Hb A2 from a cohort of 47336 indivi	5
Immature platelet fraction over time and clinical outcomes in patients with acute myocardial infarction	5
Systematic application of fluorescence in situ hybridization and immunophenotype profile for the identification of ZNF384 gene rearrangements in B cell acute lymphoblastic leukemia	5
Differential diagnosis of thalassemia and iron deficiency anemia using the CellaVision Advanced Red Blood Cell software	5
The relative expression levels of CD148 and CD180 on clonal B cells and CD148/CD180 median fluorescence intensity ratios are useful in the characterization of mature B cell lymphoid neoplasms infiltra	5
Assessing maternal clotting function with novel global coagulation assays: A prospective pilot study	5
Prospective evaluation of two specific IgG immunoassays (HemosIL® AcuStar HIT‐IgG and HAT45G®) for the diagnosis of heparin‐induced thrombocytopenia: A Bayesian approach	5
PCAT18, as a novel differentially regulated long noncoding RNA in adult acute myeloid leukemia patients revealed by next‐generation sequencing	5
Expression of CD304/neuropilin‐1 in adult b‐cell lymphoblastic leukemia/lymphoma and its utility for the measurable residual disease assessment	5
White blood cell evaluation in haematological malignancies using a web‐based digital microscopy platform	5
Prognostic evidence of LEF1 isoforms in childhood acute lymphoblastic leukemia	5
A simplified diagnostic pathway for the differential diagnosis of iron deficiency anaemia and anaemia of chronic disease	5
Pathophysiology and management of bleeding and thrombosis in patients with liver disease	5
Characteristic vacuolization of myeloid precursors and UBA1 mutation in a woman with monosomy X	5
A new approach for diagnosing hematological malignancies using monocytosis workflow optimization and abnormal lymphocyte/blast flag of Sysmex XN series of blood count analyzers	5
Epigenetic analysis reveals significant differential expression of miR‐378C and miR‐128‐2‐5p in a cohort of relapsed pediatric B‐acute lymphoblastic leukemia cases	5
Persistent hiccups in a patient with mild congenital factor V deficiency and COVID‐19; clinical and laboratory finding of a rare bleeding disorder	5
Standardization of reticulocyte counts in the athlete biological passport: A practical update	5
The utility of a myeloid mutation panel for the diagnosis of myelodysplastic syndrome and myelodysplastic/myeloproliferative neoplasm	5
Serious consequences of Epstein‐Barr virus infection: Hemophagocytic lymphohistocytosis	5
Prognostic gene expression analysis in a retrospective, multinational cohort of 155 multiple myeloma patients treated outside clinical trials	5
Machine learning models outperform manual result review for the identification of wrong blood in tube errors in complete blood count results	5
Limitations of a calibrated, quantitative APC‐R assay under routine conditions	5
Applied machine learning in hematopathology	5
GATA1 mutation analysis and molecular landscape characterization in acute myeloid leukemia with trisomy 21 in pediatric patients	5
Platelet count in sodium citrate‐anticoagulated whole blood: Comparison to EDTA‐anticoagulated results and stability over time	5
Improvement of mortality prediction accuracy in critically ill patients through combination of SOFA and APACHE II score with markers of stress haematopoiesis	5
Schistocyte quantitation, thrombotic microangiopathy and acute kidney injury in Australian snakebite coagulopathy [ASP28]	5
Mutational landscape of Juvenile Myelomonocytic Leukemia (JMML)—A real‐world context	5
Unusual inclusions in cerebrospinal fluid macrophages of spinal muscular atrophy patients treated with nusinersen	5
Profile of antiphospholipid antibodies in HIV‐infected and HIV‐uninfected women with a history of thrombosis	5
Cytomorphology of normal, reactive, dysmorphic, and dysplastic megakaryocytes in bone marrow aspirates	5
Implementation of the new EUR IVD regulation and relation with ISO15189 accreditation: Guidance is urgently required for haemostasis testing	5
Potential of point of care tests for newborn screening for sickle cell disease: Evaluation of HemotypeSC™ and sickle SCAN® in Tanzania	4
Falsely decreased FVIII activity following pneumatic tube transport	4
Interference of D‐dimer levels from heterophilic antibody in COVID‐19: A serious concern in treatment and follow‐up of patients	4
The role of cystatin C in multiple myeloma	4
Clinical and molecular characteristics of imerslund‐gräsbeck syndrome: First report of a novel Frameshift variant in Exon 11 of AMN gene	4
The value of next‐generation sequencing in routine diagnostics and management of patients with cytopenia	4
Alterations in leucocyte cell population data in bacteraemia: A study from a tertiary care hospital in India	4
Identification of peripheral blood CD26+ leukemic stem cells has a potential role in the rapid diagnosis of chronic myeloid leukemia	4
Routine haematology parameters in COVID‐19 patients and clinical outcome: A Belgian single‐centre study	4
Characterization and identification of Prachinburi β0‐thalassemia: A novel‐60 kb deletion in beta globin gene related to high levels of Hb F in heterozygous state	4
Karyotypic complexity, TP53 pathogenic variants, and increased number of variants on Next‐Generation Sequencing are associated with disease progression in a North American Adult T‐Cell Leukemia/Lympho	4
The HemoScreen hematology point‐of‐care device is suitable for rapid evaluation of acute leukemia patients	4
Measurement of antifactor VIII antibody titre in the presence of emicizumab; Use of chromogenic Bethesda assays	4
Accuracy study of a novel alternate method measuring erythrocyte sedimentation rate for prototype hematology analyzer Celltac α+	4
A retrospective study of age‐defined hematologic inflammatory markers related to pediatric COVID‐19 diagnosis	4
The diagnostic accuracy of Sysmex XN for identification of pseudothrombocytopenia using various thresholds for definition of platelet aggregation	4
Effect of the sequence of pull of bone marrow aspirates on plasma cell quantification in plasma cell proliferative disorders	4
Identification of novel mutations in patients with Diamond‐Blackfan anemia and literature review of RPS10 and RPS26 mutations	4
Analysis of laboratory blood parameter results for patients diagnosed with COVID‐19, from all ethnic group populations: A single centre study	4
Change in platelet indices in patients with Coronavirus disease‐2019 (COVID‐19): A reflection of platelet activation and contribution to immunothrombosis?	4
Reference intervals of automated reticulocyte count and immature reticulocyte fraction in a pediatric population	4
Lymphocytes screening on admission is essential for predicting in‐hospital clinical outcome in COVID‐19 patients: A retrospective cohort study	4
MicroRNAs in urine as diagnostic biomarkers for multiple myeloma	4
Evaluation of Sigma metric approach for monitoring the performance of automated analyzers in hematology unit of Alexandria Main University Hospital	4
Clinicopathological and immunophenotypic features of early T cell precursor acute lymphoblastic leukaemia: A flow cytometry score for the initial diagnosis	4
International Council for Standardization in Haematology recommendations for laboratory measurement of factor VIII and FIX type I inhibitors	4
Performance evaluation of coaguchek pro II in comparison with coaguchek XS plus and sta‐r Max using a sta‐neoplastine CI plus	4
Performance evaluation of platelet counting of Abbott Alinity hq and Sysmex XN‐9000 automated hematology analyzer compared with international reference method	4
Technological features of blast identification in the cerebrospinal fluid: A systematic review of flow cytometry and laboratory haematology methods	4
Multicentric evaluation of the variability of digital morphology performances also respect to the reference methods by optical microscopy	4
Comparison of the performance of two automatic cell morphology analyzers for peripheral‐blood leukocyte morphology analysis: Mindray MC‐100i and Sysmex DI‐60	4